Clinical trial
Phase I/II Study of Anti-HIV Cellular Therapy Based on Dendritic Cells Pulsed With Chemically Inactivated Virus
NCT02766049 is registered in ClinicalTrials.gov with University of Sao Paulo General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase I/II Study of Anti-HIV Cellular Therapy Based on Dendritic Cells Pulsed With Chemically Inactivated Virus
- Lead sponsor
- University of Sao Paulo General Hospital
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- February 28, 2010
- Completion date
- May 31, 2014
- Enrollment
- 19 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
hiv infection